- Home
- WAVE vs INDP Comparison
WAVE vs INDP Comparison
Compare WAVE & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- INDP
- Stock Information
- Founded
- WAVE 2011
- INDP 2000
- Country
- WAVE Israel
- INDP United States
- Employees
- WAVE N/A
- INDP N/A
- Industry
- WAVE Electric Utilities: Central
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- INDP Health Care
- Exchange
- WAVE Nasdaq
- INDP Nasdaq
- Market Cap
- WAVE 13.9M
- INDP 15.4M
- IPO Year
- WAVE 2021
- INDP N/A
- Fundamental
- Price
- WAVE $6.60
- INDP $1.27
- Analyst Decision
- WAVE
- INDP Strong Buy
- Analyst Count
- WAVE 0
- INDP 1
- Target Price
- WAVE N/A
- INDP $12.00
- AVG Volume (30 Days)
- WAVE 34.5K
- INDP 23.5K
- Earning Date
- WAVE 11-29-2024
- INDP 11-04-2024
- Dividend Yield
- WAVE N/A
- INDP N/A
- EPS Growth
- WAVE N/A
- INDP N/A
- EPS
- WAVE N/A
- INDP N/A
- Revenue
- WAVE $306,000.00
- INDP N/A
- Revenue This Year
- WAVE N/A
- INDP N/A
- Revenue Next Year
- WAVE N/A
- INDP N/A
- P/E Ratio
- WAVE N/A
- INDP N/A
- Revenue Growth
- WAVE 1076.92
- INDP N/A
- 52 Week Low
- WAVE $1.01
- INDP $1.03
- 52 Week High
- WAVE $6.60
- INDP $3.25
- Technical
- Relative Strength Index (RSI)
- WAVE 71.35
- INDP 47.18
- Support Level
- WAVE $4.65
- INDP $1.10
- Resistance Level
- WAVE $5.88
- INDP $1.22
- Average True Range (ATR)
- WAVE 0.83
- INDP 0.12
- MACD
- WAVE 0.13
- INDP 0.01
- Stochastic Oscillator
- WAVE 100.00
- INDP 66.67
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.